Only 1.2 kilobases (kb) at the 5' end of the 3.9-kb v-abl sequence in Abelson murine leukemia virus is required for fibroblast transformation. A precise delineation of this minimum transforming region was made by using small 5' or 3' deletions. Insertions of four amino acids, generated by putting synthetic DNA linkers into various restriction enzyme cleavage sites, abolished transforming activity, indicating that much of the internal sequence of the minimum transforming region plays a critical role in the transformation process. This 5' 1.2 kb of v-abl encodes protein-tyrosine kinase activity when expressed in Escherichia coli. Each of the mutations which caused a loss of transformation activity also resulted in a loss of protein-tyrosine kinase activity when expressed in E. coli. The minimum transforming region of v-abl contains amino acid homology to other protein-tyrosine kinase oncogenes, and a comparison with these oncogenes is presented.
Abelson murine leukemia virus (A-MuLV) is a replicationdefective retrovirus capable of transforming fibroblast cells in vitro (28) and lymphoid cells both in vitro and in vivo (1, 25, 26) . The viral genome encodes a single protein, the gene for which was produced as a result of a fusion between the Moloney MuLV (M-MuLV) gag gene and cell-derived v-abl sequences (11, 24, 32, 38, 44) . The largest variant of AMuLV encodes a 160-kilodalton (kd) protein, of which 130 kd is determined by the v-abl sequence, but only the N-terminal 45 kd of the v-abl-encoded protein sequence is required for fibroblast transformation (22) . Though nearly all of the gag sequence can be deleted without abolishing fibroblast transformation, much of gag is essential for lymphoid transformation (22) .
The v-abl gene, along with src and several other oncogenes, encode proteins that display tyrosine-specific protein kinase activity (13, 41) . In addition, these various oncogene products have a region of strongly conserved amino acid sequence (3, 23, 31) . In the v-abl-encoded protein, this homology region resides within the N-terminal 45 kd, a segment we will refer to as the minimum transforming region. J. J.-Y. Wang and D. Baltimore (J. Biol. Chem., in press) expressed this region in E. coli and found that its product displays protein-tyrosine kinase activity, demonstrating that the protein-tyrosine kinase domain and minimum transforming region are contained within the same 1.2-kilobase (kb) fragment of v-abl sequence. Witte et al. (42) showed that a transformation-defective mutant, AMuLV[P92tdJ, contains a deletion within this region and lacks tyrosine-specific in vitro autophosphorylation activity. Srinivasan et al. (34) also tested plasmids cut within this region and found them to be transformation defective.
We have now further tested the requirement for the minimum transforming region by constructing specific mutants. Small 5' or 3' deletions were made to examine the outer boundaries. Insertions of four amino acids at various points were made to test for the necessity of internal sequences. We found that nearly all the mutations within the minimum transforming region result in transformation-defective genomes. The mutant genes were expressed in Esche-Bacterial labeling. [35SJmethionine metabolic labeling and 32p; in vivo pulse-labeling of E. coli HB101 containing the various expression plasmids were performed essentially as described (39) . For [35S]methionine labeling, bacteria were grown in minimal medium containing all the amino acids except methionine. An overnight culture was diluted 1:40 into fresh methionine-free medium and incubated for 2 h at 30°C. The culture was then shifted to 40°C for 1 h. [35S]methionine was then added to 100 ,uCi/ml, and the bacteria were incubated for 1 h at 40°C. The bacteria were then collected by centrifugation and resuspended in 0.5 ml of phospholysis buffer (10 mM sodium phosphate [pH 7.5], 100 mM NaCl, 1% Triton X-100, 0.5% deoxycholate, 0.1% sodium dodecyl sulfate [SDS] , and 2 mM EDTA). The sample was sonicated twice for 15 s and centrifuged at 13 ,000 x g for 15 min. Three microliters of anti-AbT serum (a mouse serum from an animal that had rejected an A-MuLVinduced tumor [43] ) was added to the supernatant and incubated on ice for 1 h. Twenty-five microliters of a 50% protein A-Sepharose suspension was then added and incubated on ice for 30 min. The immune complexes were collected by centrifugation and washed four times in phospholysis buffer and two times in water. The complexes were then resuspended in 50 ,ul of SDS buffer (67 mM Tris-hydrochloride [pH 6.8], 2% SDS, 10% glycerol, 5 mM EDTA, 20 mM dithiothreitol, and bromophenol blue). This solution was boiled for 5 min and fractionated by electrophoresis through an SDS-10% polyacrylamide gel as described elsewhere (44 (19) and found to contain an in-frame deletion of 231 bp, removing the last 49 amino acids of gag and the first 28 amino acids of v-abl and leaving at the junction four amino acids encoded by the linker (Pro-Glu-Phe-Gly).
(iii) pABS. pABS was derived from a proviral P160-encoding clone, pABpv (22) . pABpv was partially digested with Sacl, and single-cut linear DNA was electrophoretically purified. This DNA was treated with the Klenow fragment to remove the cohesive ends. The enzyme was heat killed at 68°C for 10 min. The DNA was blunt-end ligated to recircularize it and used to transform E. coli to ampicillin resistance. The colonies were screened for intact plasmids lacking the particular Sacl site of interest due to the removal of the 4-bp cohesive ends. This puts the coding region out of frame at this point.
(iv) pPs. pPS was made similarly to pAB-p (22 Fig. 2 ).
(vi) ptX. ptX was generated from pt(b)abll30, kindly provided by Jean Wang. She placed a unique BamHI site within the small t region of the fusion protein encoded by ptabll30 (Wang and Baltimore, in press ). This plasmid was further modified to remove the EcoRI site of pBR322 in the same way as described above. To change the BamHI site to an EcoRI site, the resultant plasmid was digested with BamHI and treated with the Klenow fragment, and (EcoRI)linkers were ligated on. After extractions and ethanol precipitation the DNA was digested with EcoRI and SalI. A fragment containing EcoRI and SalI cohesive ends was electrophoretically purified, the EcoRI site then being where the BamHI site was in pt(b)abll30, leaving 58 amino acids of simian virus 40 the EcoRI site being where the first HinclI site of v-abl was (see above). This fragment corresponds to the 5' 1.8 kb of v-abl. The two fragments described above were ligated together (XhoI and Sall have compatible cohesive ends) and used to transform E. coli to ampicillin resistance. The resultant plasmid is diagrammed below (see Fig. 4 ).
(vii) ptBl. ptBl was made exactly as above, except that pBl was used instead of pRl.
(viii) ptXB1, ptXB3, ptXB4, ptXB5. ptXB1, ptXB3, ptXB4, and ptXB5 were generated as above, except that pXB1, pXB3, pXB4, or pXB5 was used instead of pRl. These plasmids were digested with HincII, and (EcoRI)linkers were ligated on at this site. The DNA was subsequently digested with EcoRI and XhoI and electrophoretically purified to generate a fragment similar to that described above, except for the linker insertion mutation in each of the plasmids.
(ix) ptHl. pt(b)abll3O was digested with BamHI and XhoI to generate the backbone fragment. pHi was digested with HincII, and 10-bp (BamHI)linkers were ligated on at this point. The DNA was digested with BamHI and XhoI to generate a fragment similar to those above, yet containing the EcoRI linker insertion present in pHi. These two gel purified DNAs were ligated together to make ptHl.
All the plasmids described under subheads vi through ix were constructed to retain the coding region of the small t-v-abl fusion protein in frame.
All restriction enzymes and Bal 31 exonuclease were obtained from New England Biolabs except for EcoRI. EcoRI, calf intestinal phosphatase, and the Klenow fragment of E. coli DNA polymerase I were from Boehringer Mannheim Biochemicals. Linker DNA and T4 DNA ligase was obtained from Collaborative Research, Inc.
RESULTS
Delineation of the minimum transforming region. We have previously shown that the 5' 1.2 kb of v-abl, when expressed as a fusion protein with the N-terminal 34 amino acids of gag (plasmid pAB-P; Fig. 1 ), is sufficient for fibroblast transformation by A-MuLV (22) . To further define the limits of this region we made small deletions at the 5' and 3' ends and tested the ability of these plasmids to transform NIH/3T3 cells.
For the 5' deletions we used Bal 31 exonuclease to generate a small deletion in a P160-coding clone (see above for details of construction). This plasmid, pBl ( Fig. 1) , was sequenced across the deletion site and was found to contain an in-frame deletion that removed the first 28 amino acids of v-abl, as well as the last 49 amino acids of gag. This region of gag is not required for fibroblast transformation (22) . Plasmid pBl did not cause transformed foci when transfected onto NIH/3T3 cells along with helper virus DNA. The helper virus DNA greatly increases the efficiency of focus formation after transfection with A-MuLV DNA (11, 12) . Use of the helper means that foci are formed by spread of virus from the initially transfected cell. Thus, even this small 5' deletion removes sequence required for transformation.
At the 3' end, a termination mutation was made at the SacI site 159 bp 5' of the PstI site used to make the transforming plasmid, pAB-P (Fig. 1) . The mutated plasmid, pABS, had its Sacl site destroyed by blunting the cohesive ends (see above for details). This resulted in putting the coding region out of frame at this point. A similar plasmid, pPS, was constructed which had only the sequence up to the Sacl site (see above). Neither pABS nor pPS transformed NIH/3T3 cells upon transfection with helper virus DNA. The 3' end of the minimum transforming region is therefore between the PstI and Sacl sites.
Linker insertion mutations in v-abl. To probe which parts of the internal sequence in the minimum transforming region of v-abl might be dispensable, we constructed a series of mutant plasmids containing 12-bp insertions within this region. These insert four amino acids while retaining the coding region in frame. The mutations were generated by partial digestion of plasmids with the restriction enzyme HaeIII to generate linear DNA. HaeIII recognizes 10 sites within the minimum transforming region, so that a partial digest generating linear DNA should result in the random cleavage at one of these sites. Linear DNA was purified from agarose gels, and 12-bp units containing restriction enzyme cleavage sites (linkers) were ligated onto this DNA. The mutations were generated in two sets by utilizing either plasmid pAB160 or pABX. For pAB160, 12- (see above for more details). Because HaeIII digestion leaves blunt ends, the above process resulted in insertion of only the 12-bp linker unit. We sequenced across each of the linker insertion mutation sites to confirm their position and sequence. As expected, all mutants contained the 12-bp linker DNA insertion within an HaeIII site. In all cases the coding region remained in frame.
The plasmids generated and the position of their linker insertions are indicated in Fig. 2 (Fig. 2) .
Mutations abolish tyrosine kinase activity. The only known biochemical activity of the A-MuLV gene product is its tyrosine-specific protein kinase activity. We were interested in determining the effects of the mutations on this activity and whether this correlated with the transforming abilities. The mutants which are defective for transformation, however, gave no phenotype when transfected into NIH/3T3 cells. In one approach to recovering cells that might express the transformation-defective proteins, we cotransfected the mutant plasmids with a construct, pSV2gpt, containing a selectable gene. Although we were able to isolate cell lines containing the mutant genomes, these cell lines were not useful for biochemical analysis of the proteins. We could detect some expression of each of the defective proteins, but their levels were low when compared with transforming proteins in infected cells. In addition, with time in culture the cell lines lost even the low level of defective protein they had synthesized. We attribute these problems to differences in expression and stability of genes in transfected versus infected cells (14) . As 54, 1985 analyze the effects of the mutations on v-abl proteins expressed in E. coli. Wang et al. (39) have shown that the v-abl protein expressed in E. coli contains protein-tyrosine kinase activity. The minimum transforming region described above is sufficient to encode this activity (Wang and Baltimore, in press). A mutant protein expressed from v-abl coding sequence only up to the Sacl site displays no protein-tyrosine kinase activity (Wang and Baltimore, in press) correlating with the inability of the equivalent mutant, pABS, to transform cells.
To determine the effect of our various mutations on the protein-tyrosine kinase activity of the protein made in E. coli, we used an expression vector employed in earlier studies (39) . It was constructed to use the lambda phage PR promoter and is heat inducible because of the inclusion in the plasmid of a temperature-sensitive cI repressor gene (Fig. 3) immunoprecipitated with anti-AbT, a serum specific for v-abl (43) . Bacteria containing only the vector, pCQV2, had some nonspecific proteins that immunoprecipitated (Fig. 4A,  lane 3) ; a plasmid encoding a wild-type v-abl protein expressed two specific proteins of 55 and 52 kd (lane 1) (Wang and Baltimore, in press). Also evident was a greatly increased amount of a 72-kd E. coli protein (Wang and Baltimore, in press). All of the mutants tested produced easily detectable amounts of abl-related proteins (Fig. 4A,  lane 2, and Fig. 4B) .
To compare the tyrosine-specific kinase activities of the proteins made in E. coli at 40°C, we labeled the bacteria with 32P042-and examined lysates for alkali-resistant phosphoproteins (39) . The wild-type v-abl product phosphorylates itself and other bacterial proteins on tyrosine when bacteria are labeled in this manner (39) , and as expected, the wildtype plasmid, ptX, caused phosphorylation of a number of bacterial proteins (Fig. 5, lane 1) . All transforming ability, it is also possible that these proteins are defective for other reasons, such as protein instability or loss of other unknown activities.
DISCUSSION
The mutants described in this paper demonstrate the importance of the 5' 1.2 kb of v-abl sequence for transformnation of NIH/3T3 cells by A-MuLV. This minimum transforming region is sufficient for transformation when expressed as a fusion protein with gag or with only the first 34 amino acids of gag (22) . Small 5' or 3' deletions into this region, as well as four amino acid insertions, produced transformation-defective viruses. The effect on protein-tyrosine kinase activity of these mutations was assayed, and in each case mutations which caused a loss of transforming activity also caused a loss of kinase activity.
Mutations within the minimum transforming region. The 5'-and 3'-end deletions described here both caused a complete transformation deficiency, indicating that the N-terminal border of the minimum transforming region lies between amino acids 5 and 28, whereas the C-terminal border is between amino acids 356 and 408. The linker insertions demonstrate the requirement for much of the internal sequence of this region. Linker insertions near the 5' end had no effect, but five of six internal insertions caused a total loss of the ability to induce transformation. The sixth, pH2, was also defective in that it had a lowered transfection efficiency and its (EcoRI)linker sequence was lost upon passage of the cells. In addition, a genome with a (BamHI)linker inserted at the same position was totally transformation defective.
Correlation of kinase activity and the minimum transforming region. As a measure of kinase activity, we expressed v-abl in E. coli and assayed for incorporation of alkali-resistant phosphate into protein. Each of the transformationdefective linker insertion mutants had lost kinase activity by this assay. The N-terminal deletion of 28 amino acids (in plasmid pB1) had a severely reduced activity. Wang and Baltimore found that a C-terminal deletion from the Sac! site also caused a loss of tyrosine kinase activity (in press).
The correlation of kinase activity and transformation ability demonstrated here strengthens the belief that the kinase activity is responsible for the transforming activity of the A-MuLV. Such experiments, however, cannot unambiguously demonstrate that kinase activity is necessary for transformation because we cannot be sure that another defect of unknown nature might not accompany the loss of kinase activity. Our inability to recover cells stably expressing the mutant protein even leaves open the possibility that instability of the protein due to intracellular proteases might correlate with loss of kinase activity. Because the linker insertion mutations are small and discrete, we doubt that all of them would induce major changes in the folding of the protein. The appearance of the same two bands of stable v-abl-encoded protein in E. coli argues that the mutations do not drastically disrupt the structure of the protein because otherwise it would be degraded in E. coli. In fact, the stability of the protein encoded by the minimum transforming region is striking-the rest of the v-abl-encoded sequence is cleaved off and degraded rapidly in E. coli (39; Wang and Baltimore, in press).
Minimum transforming region of three oncogenes encoding a kinase. The studies reported here complement work from other laboratories on mutants of viruses that encode tyrosine-specific protein kinases. In Fig. 6 , we show the location of our mutations along with others. For this purpose we have aligned three amino acid sequences, those of v-abl (23; R. Lee and D. Baltimore, unpublished data), v-src (30, 36) , and v-fps (31) (the alignment was by L. Shiman and D. Baltimore [unpublished data]). The extensive amino acid homology of these and other protein-tyrosine kinases has been widely noted (3, 23, 31) . Certain landmarks are evident, including the tyrosine phosphorylated in vivo on pp6Ov-src (30, 36) and the lysine that was affinity labeled by ATP in the cAMP-dependent protein kinase (2, 33) (both marked by asterisks in Fig. 6 ).
The sequence in Fig. 6 is limited to the region encompassing the v-abl minimum transforming region. This was defined previously for v-abl by deletions to begin no earlier than amino acid 5 and to end before the PstI site at amino acid 408 (22) . These limits can be slightly refined. (For this discussion we will refer to amino acid numbers in the v-abl sequence, but the equivalent numbers for v-src and v-fps can be interpreted from Fig. 6 .) Three insertions before amino acid 15 had no effect on transforming efficiency, suggesting that the region up to this position is not required for transformation. The deletion in pBl abolishes transformation, however, indicating that the minimum transforming region begins between amino acid 15 and 28 in v-abl. In v-fps, an insertion of three amino acids at amino acid 13 (Tyr) abolishes transformation (35) , suggesting that its minimum transforming region may also begin near this position. There is also conserved homology here among the oncogenes, suggesting an important function. For v-src, however, a deletion up to amino acid 14 did not ablate transformation of chicken embryo fibroblasts. Deletion to amino acid 31, however, virtually abolished v-src transformation (F. Cross and H. Hanafusa, personal communication), suggesting that the minimum transforming region of v-src has its 5' end near that of v-abl. Surprisingly, though, deletion of amino acids 34 to 85 in v-src gives only a temperature-sensitive transformation defect (5) , implying that, at least at the permissive temperature, this region is not needed for transformation.
The 3' end of the minimum transformation region is probably best defined by examining the amino acid homology of the three proteins. This homology extends to amino acid 377, with the v-src and v-fps genes ending soon thereafter. A v-src deletion from amino acid 366 onward is transformation defective (21) . For v-abl, some sequence beyond the Sacl site at amino acid 356 is needed, but truncation at amino acid 408 (the PstI site) leaves transforming activity. Thus, the data on the mutations are consistent with a need for the entire region of homologous sequence near the 3' end. In v-abl, 631 C-terminal amino acids follow position 377. There is no absolute requirement for this large C-terminal region of the protein, but transformation of lymphoid cells, which may be a more stringent test than transformation of fibroblasts, is more efficient when this region is left intact (22a, 27) .
Internal mutations within the v-abl minimum transforming region all either abolished or greatly affected transformation. This indicates that much of the region is required, but large segments were not probed. Earlier, the P92 transformationdefective deletion was isolated, which removed the whole central area of the minimum transforming region (11, 42) . (We have since found that it arose from a deletion which joined two in-phase 9-bp repeated sequences encoding the amino acids Met-Glu-Arg; see Fig. 6 .) Insertion mutants of Ser-Arg-Glu in the place of Tyr residues in the v-fps gene have also shown that much of the C-terminal portion of the minimum transforming region of this oncogene must be intact for transformation (35 (5) . For v-src, at least, the kinase activity appears to involve mainly the C-terminal end of the minimum transforming region. In fact, proteolysis of pp6Osrc produces a kinase-active, C-terminal, 29,000-molecular-weight fragment (4, 18) . Also, deletion of amino acids in v-src after position 366 abolishes transforming and kinase activities (see Fig. 6 
